USE OF ALDOSE REDUCTASE INHIBITORS TO ENHANCE INSULIN SENSITIVITY IN DIABETES MELLITUS - Patent 0306525

(19)

(11)

EP 0 306 525 A1

(12)

(43)	Date of publication:
	15.03.1989 Bulletin 1989/11

(21)	Application number: 88903550.0

(22)	Date of filing: 18.03.1988

(51)

International Patent Classification (IPC):

A61K 31/ 195^{( . )}
A61K 31/ 415^{( . )}
A61K 31/ 44^{( . )}
A61P 3/ 08^{( . )}

A61K 31/ 40^{( . )}
A61K 31/ 42^{( . )}
A61K 31/ 50^{( . )}

(86)	International application number:
	PCT/US1988/000814

(87)	International publication number:
	WO 1988/006887 (22.09.1988 Gazette 1988/21)

(84)	Designated Contracting States:
	AT BE CH DE FR GB IT LI LU NL SE

(30)

Priority:

20.03.1987 US 19870028512

(71)	Applicant: ALCON LABORATORIES, INC.
	Fort Worth, TX 76115 (US)

(72)	Inventor:
	YORK, Billie, M., Jr. Crowley, TX 76036 (US)

(74)	Representative: Jaeger, Klaus, Dipl.-Chem. Dr.
	Jaeger, Böck & Köster Patentanwälte Postfach 1620 D-82121 Gauting D-82121 Gauting (DE)

(54)	USE OF ALDOSE REDUCTASE INHIBITORS TO ENHANCE INSULIN SENSITIVITY IN DIABETES MELLITUS